日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

MTAP Loss Is Frequent in Oncogene-Driven NSCLC and May Confer Sensitivity to Combined PRMT5 Inhibitors and Targeted Therapies

MTAP缺失在癌基因驱动的非小细胞肺癌中很常见,并可能使肿瘤对PRMT5抑制剂和靶向治疗联合治疗敏感。

Aldea, M; Lenahan, S; Locquet, M-A; Liao, L; Gasparro, M; Gokhale, P C; Ghigna, M-R; Ionescu, D N; Odintsov, I; Ngo, K; Wang, X; Aziz, S; Pecci, F; Garbo, E; Ivanova, E; Nakazawa, S; Kulesza, J; Tsai, J A; Zullo, L; Lee, J; Zielinska, M; Simon, S; Han, D; Marinello, A; Li, G; Rossato de Almeida, G; Huang, J; Paoloni, F; Gariazzo, E; Santo, V; Remon, J; Marks, J A; LoPiccolo, J; Florez, N; Nishino, M; Ricciuti, B; Luo, J; Barbie, D A; Planchard, D; Rotow, J K; Barlesi, F; Graf, R P; Feng, W W; Besse, B; Paweletz, C; Sholl, L; Shaw, A T; Jänne, P A

The NOTCH3 extracellular domain is a serum biomarker for pulmonary arterial hypertension

NOTCH3胞外结构域是肺动脉高压的血清生物标志物。

Hernandez, Moises; Winicki, Nolan M; Puerta, Cristian D; Lakshminarayanan, Swetha; Zhang, Yu; Ramirez-Sanchez, Israel; Besse, Casandra E; Liu, Lin; Poch, David S; Yuan, Jason X-J; Shyy, John Y-J; Yu, Paul B; Garcia, Joe G N; Thistlethwaite, Patricia A

Repotrectinib in NTRK fusion-positive advanced solid tumors: a phase 1/2 trial

瑞波替尼治疗NTRK融合阳性晚期实体瘤:一项1/2期试验

Besse, Benjamin; Lin, Jessica J; Bazhenova, Lyudmila; Goto, Koichi; de Langen, Adrianus Johannes; Kim, Dong-Wan; Wolf, Jürgen; Springfeld, Christoph; Popat, Sanjay; Lim, Darren W T; Nagasaka, Misako; Hong, Jung Yong; Baik, Christina S; Hervieu, Alice; Moreno, Victor; Yang, Nong; Kollengode, Kanthi; Yang, Haisu; Xu, Yuanfang; Calvet, Christophe Y; Yuan, Yong; Hammell, Amy B; Drilon, Alexander; Solomon, Benjamin J

Amivantamab Plus Lazertinib in Atypical EGFR-Mutated Advanced Non-Small Cell Lung Cancer: Results From CHRYSALIS-2

阿米万他单抗联合拉泽替尼治疗非典型 EGFR 突变型晚期非小细胞肺癌:CHRYSALIS-2 研究结果

Tomasini, Pascale; Wang, Yongsheng; Li, Yongsheng; Felip, Enriqueta; Wu, Lin; Cui, Jiuwei; Besse, Benjamin; Spira, Alexander I; Neal, Joel W; Goto, Koichi; Baik, Christina S; Marmarelis, Melina E; Ichihara, Eiki; Zhang, Yiping; Lee, Jong-Seok; Lee, Se-Hoon; Yang, James Chih-Hsin; Michels, Sebastian; Anastasiou, Zacharias; Curtin, Joshua C; Lyu, Xuesong; Mahoney, Janine; Demirdjian, Levon; Meyer, Craig S; Zhang, Youyi; Leconte, Isabelle; Lorenzini, Patricia; Knoblauch, Roland E; Trani, Leonardo; Baig, Mahadi; Bauml, Joshua M; Cho, Byoung Chul

Boosting CAR T-cell efficacy by blocking proteasomal degradation of membrane antigens

通过阻断膜抗原的蛋白酶体降解来提高CAR T细胞的疗效

Rieger, Leonie; Irlinger, Kilian; Füchsl, Franziska; Tietje, Marlene; Purcarea, Anna; Barbian, Nicolas; Faber, Melanie; Vogelsang, Carolin; Pfeuffer, Lisa; Stotz, Sonja; Karpiuk, Oleksandra; Schulze, Tobias; Augsburger, Abirami; Glaisner, Nadine; Konetzki, Verena; Friedel, Sabrina; Besse, Andrej; Besse, Lenka; Driessen, Christoph; Buchner, Maike; Schwamborn, Kristina; Steiger, Katja; Giansanti, Piero; Theurich, Sebastian; Waldschmidt, Johannes; Kortüm, K Martin; Hudecek, Michael; Einsele, Hermann; Högner, Marion; Kuster, Bernhard; Krackhardt, Angela M; Hecker, Judith S; Bassermann, Florian

Outcomes and Treatments of Patients With Non-Small Cell Lung Cancer Who Received Pembrolizumab

接受帕博利珠单抗治疗的非小细胞肺癌患者的预后和治疗

Rousseau, Adrien; Foulon, Stéphanie; Planchard, David; Remon, Jordi; Barlesi, Fabrice; Lavaud, Pernelle; Frelaut, Maxime; Aldea, Mihaela; Parisi, Claudia; Gazzah, Anas; Le Pechoux, Cécile; Botticella, Angela; Levy, Antonin; Simon-Tillaux, Noémie; Michiels, Stefan; Besse, Benjamin

Tackling the diagnosis of HA20 in children: challenges of a highly variable clinical and genetic spectrum

儿童HA20诊断的挑战:高度可变的临床和遗传谱带来的挑战

Anselmi, Federica; Frémond, Marie-Louise; Remaux, Heloise; Laurent, Audrey; Fieschi, Claire; Schvartz, Adrien; Desdoits, Alexandra; Besse, Marie Charlotte; Jesiorski, Eric; Boursier, Guilaine; Cuisset, Laurence; Dusser, Perrine; Koné-Paut, Isabelle

Promoter hypomethylation drives ABCB1-mediated carfilzomib resistance in multiple myeloma

启动子低甲基化驱动多发性骨髓瘤中ABCB1介导的卡非佐米耐药性

Han, Seungbin; Haertle, Larissa; Munawar, Umair; Truger, Marietta; Hainold, Ann-Sophie; Lee, Chien-Yun; Kurian, Shilpa; Verbruggen, Christina; Nerreter, Silvia; Vogt, Cornelia; Besant, Emma; Rein, Nina; Lehmann, Johanna; Köppel, Max; Tamamushi, Yoko; Zhou, Xiang; Steinbrunn, Torsten; Haaf, Thomas; Küster, Bernhard; Slaby, Ondrej; Haferlach, Claudia; Einsele, Hermann; Rasche, Leo; Waldschmidt, Johannes; Besse, Andrej; Driessen, Christoph; Besse, Lenka; Kortüm, K Martin

Development and validation of a PSMA-positive triple-negative breast cancer mouse model for preclinical targeted radionuclide therapies.

开发和验证 PSMA 阳性三阴性乳腺癌小鼠模型,用于临床前靶向放射性核素治疗。

Chaussin Benjamin, Sanchez Lucie, Levesque Sophie, Revy Alban, Tempier Marion, Montemagno Christopher, Durivault Jérôme, Schmitt Sébastien, Boutault Erwan, Besse Sophie, Chautard Emmanuel, Auriol Manon, Voissiere Aurélien, Kossaï Myriam, Miot-Noirault Elisabeth, Penault-Llorca Frédérique, Merlin Charles, Cachin Florent, Jouberton Elodie

Inhibition of cell surface GRP78 on brain tumors reverses drug resistance and stops cancer stem cell expansion.

抑制脑肿瘤细胞表面的 GRP78 可逆转耐药性并阻止癌症干细胞的扩增。

Stolarik Elizabeth, Zelek Jorryn, Thigpen Mariah, Muller-Greven Gaelle, Besse Rafaela, Jakkala Shanuja, Davidson Anita K, Gladson Candece L, Davidson Donald J